β 2-Adrenoceptor and insulin receptor expression in the skeletal muscle of streptozotocin induced diabetic rats: Antagonism by vitamin D 3 and curcumin

European Journal of Pharmacology

Volumn 687, Issue 1-3, 2012, Pages 14-20

  Xavier, Serene ^a   Sadanandan, Jayanarayanan ^a   George, Naijil ^a   Paulose, Chiramadathikudiyil Skaria ^a  

^a Department of Physics   (India)

Author keywords

2 Adrenoceptor; Curcumin; Diabetes; Insulin receptor; Skeletal muscle; Vitamin D 3

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; COLECALCIFEROL; CURCUMIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOSE; GLYCOGEN; INSULIN; INSULIN RECEPTOR; INSULIN ZINC SUSPENSION; MALATE DEHYDROGENASE; PROPRANOLOL; PROTEIN KINASE B; STREPTOZOCIN; TRITIUM;

AKT GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA2 ADRENOCEPTOR GENE; BINDING ASSAY; CONTROLLED STUDY; CREB GENE; CYTOSOL; DIABETES MELLITUS; DISSOCIATION CONSTANT; ENZYME ACTIVITY; GENE EXPRESSION; GLUCONEOGENESIS; GLYCEMIC CONTROL; GLYCOGENOLYSIS; INSULIN BLOOD LEVEL; INSULIN RECEPTOR GENE; MALE; MITOCHONDRION; MOLECULAR PROBE; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SKELETAL MUSCLE; STREPTOZOCIN DIABETES; WEIGHT CONTROL;

ANIMALS; BLOOD GLUCOSE; CHOLECALCIFEROL; CURCUMIN; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION; INSULIN; MALATE DEHYDROGENASE; MALE; MUSCLE, SKELETAL; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; RECEPTOR, INSULIN; RECEPTORS, ADRENERGIC, BETA-2; RNA, MESSENGER; STREPTOZOCIN;

EID: 84862013005     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.02.050     Document Type: Article

References (35)

1. Accili, D., Drago, J., Lee, E.J., Johnson, M.D., Cool, M.H., Salvatore, P., Asico, L.D., José, P.A., Taylor, S.A., Westphal, H., 1996. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat. Genet. 12, 106-109. (Pubitemid 26013160)
2. Arai, T., Nakamura, M., Magori, E., Fukuda, H., Sako, T., 2003. Decrease in malate dehydrogenase activities in peripheral leucocytes of type 1 diabetic dogs. Res. Vet. Sci. 74, 183-185. (Pubitemid 36395603)
3. Cédola, N., Cabarrou, A., Auciello, N., Doria, I., Ponce de León, H., Baylon, N., 1975. The liver in human diabetes - concentration of some induced enzymes. Acta Diabetol. Lat. 12, 263-271.
4. Chiu, K.C., Chu, A., Go, V.L., Saad, M.F., 2004. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 79, 820-825. (Pubitemid 41103882)
5. Commandeur, J.N.M., Vermeulen, N.P.E., 1996. Cytotoxicity and cytoprotective activities of natural compounds the case of curcumin. Xenobiotica 26, 667-680. (Pubitemid 26233021)
6. de Sousa Santos, R., Vianna, L.M.T., 2005. Effect of cholecalciferol supplementation on blood glucose in an experimental model of type 2 diabetes mellitus in spontaneously hypertensive rats and Wistar rats. Clin. Chim. Acta 358, 146-150.
7. Herman, W.H., Crofford, O.B., 1997. The relationship between diabetic control and complications. In: Pickup, J.C., Williams, G. (Eds.), Textbook of Diabetes. Blackwell Scientific Oxford, pp. 41.1-41.11.
8. Johnson, D., Lardy, H., 1947. In: Estarbook, R.W. (Ed.), Isolation of Mitochondria - Methods in Enzymology. Academic Press, London, pp. 94-96.
9. Junod, A., Lambert, A.E., Staufferacher, W., Renold, A.E., 1969. Diabetogenic action of streptozotocin relationship of dose to metabolic response. J. Clin. Invest. 48, 2129-2139.
10. Kadowaki, S., Norman, A.W., 1985. Demonstration that the vitamin D metabolite 1,25(OH)2-vitamin D3 and not 24R,25(OH)2-vitamin D3 is essential for normal insulin secretion in the perfused rat pancreas. Diabetes 34, 315-320. (Pubitemid 15143711)
11. Kamalakkannan, G., Petrilli, C.M., George, I., 2008. Clenbuterol increases lean muscle mass but not endurance in patients with chronic heart failure. J. Heart Lung Transplant. 27, 457-461. (Pubitemid 351418249)
12. Kim, T., Davis, J., Zhang, A.J., He, X., Mathews, S.T., 2009. Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells. Biochem. Biophys. Res. Commun. 388, 377-382.
13. Kline, W.O., Panaro, F.J., Yang, H., Bodine, S.C., 2007. Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol. J. Appl. Physiol. 102, 740-747. (Pubitemid 46220906)
14. Lee, S., Clark, S.A., Gill, R.K., Christakos, S., 1994. 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion. Endocrinology 134, 1602-1610.
15. Like, A.A., Rossini, A.A., 1976. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193, 415-417.
16. Lowry, O.H., Rosenbrough, N.H., Farr, A.L., Randall, R.J., 1951. Protein measurement with folin phenol reagent. J. Biol. Chem. 193, 265-275.
17. Luttrell, M., 2002. Activation and targeting of mitogen-activated protein kinases by G-protein-coupled receptors. Can. J. Pharmacol. 80, 375-382.
18. Norman, A.W., Frankel, J.B., Heldt, A.M., Grodsky, G.M., 1980. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209, 823-825. (Pubitemid 10017495)
19. Paik, J.W., Gooze, L.L., Haussler, M.R., 1980. Biochemical evidence for 1,25-dihydroxyvitamin D3 receptor-like macromolecule in parathyroid, pancreatic, pituitary and placental tissue. Life Sci. 26, 407-416.
20. Prokhorova, M.I., 1982. Methods of biochemical studies [in Russian]. Leningrad 45, 177-178.
21. Pronobesh, C., Dagagi, A.V., Pallab, C., Kumar, W.A., 2008. Protective role of the calcium channel blocker amlodipine against mitochondrial injury in ischemia and reperfusion injury of rat liver. Acta Pharm. 58, 421-428.
22. Rang, H.P., Maureen Dale, M., 2003. Pharmacology, third ed. Churchill Livingstone, Edinburgh.
23. Rudnicki, P.M., Molsted-Pedersen, L., 1997. Effect of 1,25-dihydroxycholecalciferol on glucose metabolism in gestational diabetes mellitus. Diabetologia 40, 40-44. (Pubitemid 27035708)
24. Scatchard, G., 1949. The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci. 51, 660-672.
25. Seema, P.V., Sudha, B., Padayatti, P.S., Abraham, A., Reghu, K.G., Paulose, C.S., 1996. Kinetic studies of purified MDH in the liver of streptozotocin induced diabetic rats and the effect of leaf extract of Aegle marmelos Correa ex Roxb. Indian J. Exp. Biol. 34, 600-602.
26. Sharma, S., Kulkarni, S.K., Chopra, K., 2006. Curcumin the active principle turmeric Curcuma longa, ameliorates diabetic nephropathy in rats. Clin. Exp. Pharmacol. Physiol. 33, 940-945. (Pubitemid 44427317)
27. Srinivasan, A., Menon, V.P., Periaswamy, V., Rajasekaran, K.N., 1972. Protection of pancreatic beta-cell by the potential antioxidant bis-o-hydroxycinnamoyl methane, analogue of natural curcuminoid in experimental diabetes. J. Pharm. Pharm. Sci. 6, 327-333.
28. Surh, Y.J., Chun, K.S., Cha, H.H., Han, S.S., Keum, Y.S., Park, K.K., Lee, S.S., 2001. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals, down-regulation of COX-2 and iNOS through suppression of NF kappa B activation. Mutat. Res. 480, 243-268. (Pubitemid 32744832)
29. 3H] catecholamines to alphanoradrenergic receptor sites in calf brain. J. Biol. Chem. 252, 6450-6463.
30. Ward, C.W., Lawrence, M.C., 2009. Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor. Bioassays 31, 422-434.
31. Widegren, U., Ryder, J.W., Zierath, J.R., 2001. Mitogen-activated protein kinase signal transduction in skeletal muscle: effects of exercise and muscle contraction. Acta Physiol. Scand. 172, 227-238. (Pubitemid 33757163)
32. Wild, S., Roglic, G., Green, A., Sicree, R., King, H., 2004. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053. (Pubitemid 38579764)
33. Williams, J.H., Barnes, 1998. The positive inotropic effect of epinephrine on skeletal muscle: a brief review. Muscle Nerve 12, 968-975.
34. Winder, W.W., Hardie, D.G., 1999. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am. J. Physiol. 277, 3-10.
35. Zdychova, J., Komers, R., 2004. Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications. Physiol. Res. 54, 1-16. (Pubitemid 40363649)